EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vascular smooth muscle cell–derived KIF13B inhibits proinflammatory responses to protect against atherosclerosis

Guolin Miao, Yufei Han, Jingxuan Chen, Yiran Liu, Ge Zhang, Shaotong Pei, Yinqi Zhao, Yitong Xu, Liwen Zheng, Zhaoling Li, Xiangru Liu, Sijing Shi und 8 weitere

Journal of Clinical Investigation · 16.03.2026 · 136 (6)

DOI: 10.1172/jci194175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 29.01.2026. Verfasst von Guolin Miao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Kinesins, Atherosclerosis, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, NA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death worldwide, with plaque instability being a major culprit. Phenotypic switching of vascular smooth muscle cells (VSMCs) is a central event in atherosclerosis, driving both plaque progression and stability, yet the underlying mechanisms are incompletely understood, limiting drug development targeting this process. Kinesin family member 13B (KIF13B) has been implicated in vascular biology, but its function in VSMCs is unknown. Here, we demonstrate that VSMC-specific deletion of Kif13b in mice overexpressing proprotein convertase subtilisin/kexin type 9 (PCSK9) exacerbates lesion development and impairs plaque stability, characterized by thinner fibrous caps and increased inflammation. Mechanistically, we determined that KIF13B facilitated the ubiquitination and proteasomal degradation of Krüppel-like factor 4 (KLF4) through the potassium channel tetramerization domain–containing 10–dependent (KCTD10-dependent) pathway. This KIF13B/KCTD10 axis reduced KLF4 protein levels, thereby inhibiting the proinflammatory responses and fibroblast-like transition of VSMCs to preserve their contractile phenotype. Importantly, the adverse effects of Kif13b deficiency on atherogenesis were effectively rescued by the small-molecule KLF4 inhibitor Kenpaullone. Our results unveil a VSMC-specific atheroprotective role for KIF13B, define the KIF13B/KCTD10/KLF4 pathway as a key regulatory axis governing VSMC fate and plaque stability, and validate the therapeutic potential of KIF13B for treating advanced atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KinesinsAtherosclerosisMuscle, Smooth, VascularMyocytes, Smooth MuscleAnimalsKruppel-Like Factor 4MiceHumansKruppel-Like Transcription FactorsInflammationMice, Knockout

Stichwörter der Autor:innen

AtherosclerosisCardiologyVascular biology

Substanzen

Kruppel-Like Factor 4KinesinsKlf4 protein, mouseKLF4 protein, humanKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
  • Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, and.
  • Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Research Center for Cardiopulmonary Rehabilitation, University of Health and Rehabilitation Sciences Qingdao Hospital (Qingdao Municipal Hospital), School of Health and Life Sciences, University of Health and Rehabilita…
  • Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

Förderung

  • the National Natural Science Foundation of China
  • NA

Zitieren

APA

Miao, G., Han, Y., Chen, J., Liu, Y., Zhang, G., Pei, S., Zhao, Y., Xu, Y., Zheng, L., Li, Z., Liu, X., Shi, S., Kang, X., Liu, Y., Zhang, L., Huang, W., Wang, Y., Tang, J., Dong, E., & Xian, X. (2026). Vascular smooth muscle cell–derived KIF13B inhibits proinflammatory responses to protect against atherosclerosis. Journal of Clinical Investigation, 136(6). https://doi.org/10.1172/jci194175

Vancouver

Miao G, Han Y, Chen J, Liu Y, Zhang G, Pei S, et al. Vascular smooth muscle cell–derived KIF13B inhibits proinflammatory responses to protect against atherosclerosis. Journal of Clinical Investigation. 2026;136(6). doi:10.1172/jci194175

BibTeX
@article{Miao2026,
  author = {Miao, Guolin and Han, Yufei and Chen, Jingxuan and Liu, Yiran and Zhang, Ge and Pei, Shaotong and Zhao, Yinqi and Xu, Yitong and Zheng, Liwen and Li, Zhaoling and Liu, Xiangru and Shi, Sijing and Kang, Xuya and Liu, Yahan and Zhang, Ling and Huang, Wei and Wang, Yuhui and Tang, Junnan and Dong, Erdan and Xian, Xunde},
  title = {Vascular smooth muscle cell–derived KIF13B inhibits proinflammatory responses to protect against atherosclerosis},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {6},
  doi = {10.1172/jci194175}
}
Kostenlos starten →